Developer docs
API playgroundTry for free, no card

Search company profiles

Galenica

Full company profile

uuid000n9tj

Namestring
Galenica
Legal namestring
Galenica S.A.
Websiteurl
galenica.gr
Company typeenum
Private
Founded yearint
1974
Descriptiontext

Galenica S.A. is a privately held Greek pharmaceutical manufacturer founded in 1974, headquartered in Kifissia, Greece, with manufacturing facilities in Chalkida and Kryoneri and a regional office in Pilea (North Greece). The company develops, manufactures, and distributes a portfolio spanning prescription medicines and over-the-counter (OTC) products across 10 therapeutic areas, serving healthcare providers and patients through pharmacy, hospital, and wholesale distribution channels.

Galenica operates an export-driven business model, distributing products to 50+ international markets through a network of 60+ pharmaceutical partners accumulated over more than 50 years of operation. The company holds BS EN ISO 14001:2015 environmental management certification and maintains a formal pharmacovigilance program, supporting regulatory positioning across regulated markets. Its technology stack is centered on conventional pharmaceutical manufacturing rather than digital or AI-driven platforms, with no disclosed APIs, software products, or proprietary AI assets.

The firm operates with a workforce of 101–250 employees and generates revenue through one-time sales of manufactured pharmaceutical products into prescription and OTC channels. Pricing is not publicly disclosed and is consistent with regulated pharmacy-channel economics. No funding rounds, M&A activity, named end-customer accounts, or management team details are publicly available, leaving ownership structure and revenue scale undisclosed.

Short descriptiontext

Galenica S.A. is a privately held Greek pharmaceutical manufacturer founded in 1974 that produces prescription medicines and OTC products across 10 therapeutic areas at plants in Chalkida and Kryoneri, distributing to 50+ export markets through 60+ international pharmaceutical partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersKifissia, Greece
HQ citystring
Kifissia
HQ countrystring
Greece
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
prescription medicines, OTC pharmaceuticals, pharmaceutical manufacturing, therapeutic products, generic medications
Industry3 codes
1OTC & Consumer Health Distributors
CodeHLAIAJACPrimaryYes
2OTC Medicines & Consumer Health Products Distribution
CodeCRAOAHABPrimaryNo
3Prescription Pharmaceutical (Rx) Wholesale Distribution
CodeCRAOAHAAPrimaryNo
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Manufacturing
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Products
TypeOne Time License
Description

Revenue from manufacturing and distribution of prescription medicines and over-the-counter (OTC) pharmaceutical products

galenica.gr
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Galenica manufactures and distributes prescription (Rx) medicines and over-the-counter (OTC) pharmaceutical products from its production facilities in Chalkida and Kryoneri, Greece. The company operates across 10 therapeutic areas and exports to more than 50 international markets through pharmaceutical distribution channels including pharmacies, hospitals, and healthcare providers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Galenica is a pharmaceutical company operating in Greece with a diversified product portfolio consisting of two main categories: Prescription Medicines (Rx) and Over-the-Counter (OTC) products. The company manufactures pharmaceutical products at its facilities in Chalkida and Kryoneri, Greece, and distributes them to export markets globally. The portfolio spans multiple therapeutic areas, serving both healthcare professional-prescribed treatments and consumer-accessible self-care solutions.

Product and service2 records
1Prescription Medicines
CategoryPrescription Pharmaceuticals
Description

Prescription-only pharmaceutical products manufactured by Galenica for treating various medical conditions across 10 therapeutic areas. Sold through healthcare provider prescriptions to pharmacies, hospitals, and authorized pharmaceutical distributors in domestic and export markets.

2OTC (Over-the-Counter) Products
CategoryConsumer Health Products
Description

Non-prescription pharmaceutical products manufactured by Galenica, available directly to consumers for self-medication. Distributed through pharmacy retail channels and healthcare networks in Greece and international export markets.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1International Pharmaceutical Partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Galenica maintains partnerships with pharmaceutical companies globally, with over 60 partners worldwide, focusing on therapeutic areas and pharmaceutical product development and distribution

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1ELPEN Pharmaceutical
TypeDirect peer
Description

Greek pharmaceutical manufacturer with a diversified Rx and OTC portfolio and export operations. Directly comparable to Galenica in therapeutic breadth, domestic market position, and Greek manufacturing footprint.

2Demo SA
TypeDirect peer
Description

One of the largest Greek pharmaceutical manufacturers, producing generics, OTC products, and injectables for domestic and international markets. Highly comparable in business model, export orientation, and product mix.

3Vianex (Vian Pharmaceuticals)
TypeDirect peer
Description

Greek pharmaceutical manufacturer with manufacturing facilities and an export business across multiple therapeutic categories. Comparable to Galenica in scale, Greek manufacturing base, and international distribution model.

4Pharmathen
TypeDirect peer
Description

Greek-based pharmaceutical company specializing in generics and complex formulations with strong export presence. Comparable to Galenica in Greek manufacturing origin and international generic market participation.

5Help Pharmaceuticals
TypeDirect peer
Description

Greek pharmaceutical manufacturer focused on prescription generics and OTC products, exporting across multiple markets. Directly comparable to Galenica in product mix and Greek-based manufacturing.

6Krka
TypeDirect peer
Description

Slovenian-headquartered generic pharmaceutical manufacturer with extensive international sales across more than 50 markets. Comparable to Galenica in generic-focused manufacturing model and broad geographic footprint.

7Stada Arzneimittel
TypeBroad incumbent
Description

European-focused generic and consumer healthcare company with broad Rx and OTC portfolios across multiple European markets. Comparable to Galenica in product categories but operates at a significantly larger scale.

8Teva Pharmaceutical Industries
TypeBroad incumbent
Description

Global generic pharmaceutical leader with manufacturing and commercial operations worldwide, including in Greece. Comparable as a direct competitor in generic categories where Galenica also operates.

9Hikma Pharmaceuticals
TypeBroad incumbent
Description

Multinational generic and specialty pharmaceutical manufacturer with significant MENA and European presence. Comparable to Galenica in generic manufacturing and export-driven revenue model.

10Almirall
TypeRegional player
Description

European specialty pharmaceutical company headquartered in Spain with focus on dermatology and other therapeutic areas. Comparable in Mediterranean regional positioning and European market focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Galenica

Pharmaceutical Manufacturinggalenica.gr

Galenica S.A. is a privately held Greek pharmaceutical manufacturer founded in 1974 that produces prescription medicines and OTC products across 10 therapeutic areas at plants in Chalkida and Kryoneri, distributing to 50+ export markets through 60+ international pharmaceutical partners.

What Galenica does

Galenica S.A. is a privately held Greek pharmaceutical manufacturer founded in 1974, headquartered in Kifissia, Greece, with manufacturing facilities in Chalkida and Kryoneri and a regional office in Pilea (North Greece). The company develops, manufactures, and distributes a portfolio spanning prescription medicines and over-the-counter (OTC) products across 10 therapeutic areas, serving healthcare providers and patients through pharmacy, hospital, and wholesale distribution channels.

Galenica operates an export-driven business model, distributing products to 50+ international markets through a network of 60+ pharmaceutical partners accumulated over more than 50 years of operation. The company holds BS EN ISO 14001:2015 environmental management certification and maintains a formal pharmacovigilance program, supporting regulatory positioning across regulated markets. Its technology stack is centered on conventional pharmaceutical manufacturing rather than digital or AI-driven platforms, with no disclosed APIs, software products, or proprietary AI assets.

The firm operates with a workforce of 101–250 employees and generates revenue through one-time sales of manufactured pharmaceutical products into prescription and OTC channels. Pricing is not publicly disclosed and is consistent with regulated pharmacy-channel economics. No funding rounds, M&A activity, named end-customer accounts, or management team details are publicly available, leaving ownership structure and revenue scale undisclosed.

Galenica firmographics

Firmographics
Name
Galenica
Legal name
Galenica S.A.
Website
https://galenica.gr
Company type
Private
Founded year
1974
Operating status
Operating
Headcount range
101–250 employees
Short description
Galenica S.A. is a privately held Greek pharmaceutical manufacturer founded in 1974 that produces prescription medicines and OTC products across 10 therapeutic areas at plants in Chalkida and Kryoneri, distributing to 50+ export markets through 60+ international pharmaceutical partners.
Ownership category
akta.pro rank

Galenica industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro primary industry
OTC & Consumer Health Distributors (HLAIAJAC)
akta.pro secondary industries
OTC Medicines & Consumer Health Products Distribution (CRAOAHAB), Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)

Keywords

  • Prescription medicines
  • OTC pharmaceuticals
  • Pharmaceutical manufacturing
  • Therapeutic products
  • Generic medications

Where Galenica is headquartered

Location

Headquarters

HQ city
Kifissia
HQ country
Greece
HQ region
Europe

Offices4 records

Markets served

Galenica business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Pharmaceutical Products: Revenue from manufacturing and distribution of prescription medicines and over-the-counter (OTC) pharmaceutical products

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Galenica product offering

Product offering

Core offering

Galenica manufactures and distributes prescription (Rx) medicines and over-the-counter (OTC) pharmaceutical products from its production facilities in Chalkida and Kryoneri, Greece. The company operates across 10 therapeutic areas and exports to more than 50 international markets through pharmaceutical distribution channels including pharmacies, hospitals, and healthcare providers.

Product overview

Galenica is a pharmaceutical company operating in Greece with a diversified product portfolio consisting of two main categories: Prescription Medicines (Rx) and Over-the-Counter (OTC) products. The company manufactures pharmaceutical products at its facilities in Chalkida and Kryoneri, Greece, and distributes them to export markets globally. The portfolio spans multiple therapeutic areas, serving both healthcare professional-prescribed treatments and consumer-accessible self-care solutions.

Differentiator

Problem solved

Functional benefit

Products and services

  • Prescription Medicines Prescription-only pharmaceutical products manufactured by Galenica for treating various medical conditions across 10 therapeutic areas. Sold through healthcare provider prescriptions to pharmacies, hospitals, and authorized pharmaceutical distributors in domestic and export markets.
  • OTC (Over-the-Counter) Products Non-prescription pharmaceutical products manufactured by Galenica, available directly to consumers for self-medication. Distributed through pharmacy retail channels and healthcare networks in Greece and international export markets.

Companies that use Galenica

Customer profile

Segments1 record

Ideal customer profiles1 record

Galenica technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Galenica partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • International Pharmaceutical PartnerscoreStrategic or Co-development PartnerGalenica maintains partnerships with pharmaceutical companies globally, with over 60 partners worldwide, focusing on therapeutic areas and pharmaceutical product development and distribution

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Galenica competitors and assessment

Company assessment

Direct peers

  • ELPEN Pharmaceutical: Greek pharmaceutical manufacturer with a diversified Rx and OTC portfolio and export operations. Directly comparable to Galenica in therapeutic breadth, domestic market position, and Greek manufacturing footprint.
  • Demo SA: One of the largest Greek pharmaceutical manufacturers, producing generics, OTC products, and injectables for domestic and international markets. Highly comparable in business model, export orientation, and product mix.
  • Vianex (Vian Pharmaceuticals): Greek pharmaceutical manufacturer with manufacturing facilities and an export business across multiple therapeutic categories. Comparable to Galenica in scale, Greek manufacturing base, and international distribution model.
  • Pharmathen: Greek-based pharmaceutical company specializing in generics and complex formulations with strong export presence. Comparable to Galenica in Greek manufacturing origin and international generic market participation.
  • Help Pharmaceuticals: Greek pharmaceutical manufacturer focused on prescription generics and OTC products, exporting across multiple markets. Directly comparable to Galenica in product mix and Greek-based manufacturing.
  • Krka: Slovenian-headquartered generic pharmaceutical manufacturer with extensive international sales across more than 50 markets. Comparable to Galenica in generic-focused manufacturing model and broad geographic footprint.

Broad incumbents

  • Stada Arzneimittel: European-focused generic and consumer healthcare company with broad Rx and OTC portfolios across multiple European markets. Comparable to Galenica in product categories but operates at a significantly larger scale.
  • Teva Pharmaceutical Industries: Global generic pharmaceutical leader with manufacturing and commercial operations worldwide, including in Greece. Comparable as a direct competitor in generic categories where Galenica also operates.
  • Hikma Pharmaceuticals: Multinational generic and specialty pharmaceutical manufacturer with significant MENA and European presence. Comparable to Galenica in generic manufacturing and export-driven revenue model.

Regional players

  • Almirall: European specialty pharmaceutical company headquartered in Spain with focus on dermatology and other therapeutic areas. Comparable in Mediterranean regional positioning and European market focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Galenica social profiles

Digital presence

Galenica compliance and trust

Trust signal

Compliance1 record

Galenica financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Galenica leadership team

Management profile

Number of profiles

Galenica funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Galenica M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Galenica

What does Galenica do?

Galenica manufactures and distributes prescription (Rx) medicines and over-the-counter (OTC) pharmaceutical products from its production facilities in Chalkida and Kryoneri, Greece. The company operates across 10 therapeutic areas and exports to more than 50 international markets through pharmaceutical distribution channels including pharmacies, hospitals, and healthcare providers.

Is Galenica a public or private company?

Galenica is a private company. It is classified as unknown and is currently operating.

When was Galenica founded?

Galenica was founded in 1974. It employs 101 to 250 people.

Where is Galenica based?

Galenica is headquartered in Kifissia, Greece, in the Europe region.

How does Galenica make money?

One revenue line is on record: pharmaceutical Products.

Who are Galenica's main competitors?

Direct peers on record are ELPEN Pharmaceutical, Demo SA, Vianex (Vian Pharmaceuticals), Pharmathen, Help Pharmaceuticals and Krka. Broad incumbents are Stada Arzneimittel, Teva Pharmaceutical Industries and Hikma Pharmaceuticals. Almirall is listed as a regional player.

Does Galenica have an API?

No public API is recorded for Galenica.

What industry is Galenica in?

Galenica's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAJAC, OTC & Consumer Health Distributors, with a secondary code of CRAOAHAB, OTC Medicines & Consumer Health Products Distribution. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales